Article History
Received: 30 October 2023
Accepted: 2 December 2023
First Online: 14 December 2023
Declarations
:
: Not applicable.
: Not applicable.
: CHM has received fees for advisory board for Apellis and lectures for Bayer. GBM is a scientific consultant to SJJ Solutions and Molecular Partners, and has been part of advisory boards of Bayer, Molecular Partners, and Roche. AMK is a consultant for Apellis and Iveric Bio and receives research grants from Apellis and Iveric Bio.GBM is editor-in-chief of International Journal of Retina and Vitreous. This article was independently handled by a member of the Editorial Board.